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Abstract
Background: Gamisoyo-san (GMSYS) is a traditional herbal formula used to treat insomnia, dysmenorrhea, and
infertility in Korea. The purpose of this study was to investigate the anti-inflammatory effect and action mechanisms
of GMSYS in lipopolysaccharide (LPS)-stimulated RAW 264.7 macrophages.
Methods: The anti-inflammatory effects of GMSYS were investigated using nitric oxide (NO) assay and ELISAs for
prostaglandin E2 (PGE2), tumor necrosis factor-α (TNF-α), and interleukin-6 (IL-6). The anti-inflammatory action
mechanisms of GMSYS were evaluated using Western blotting for inducible nitric oxide synthase (iNOS),
cyclooxygenase-2 (COX-2), and activation of nuclear transcription factor kappa B (NF-κB) and mitogen-activated
protein kinases (MAPKs).
Results: GMSYS significantly inhibited the LPS-induced production of NO, PGE2, TNF-α, and IL-6 compared with the
vehicle-treated cells. GMSYS consistently downregulated the expression of iNOS and COX-2 mRNA induced by LPS.
In addition, pretreatment with GMSYS suppressed the LPS-induced activation of NF-κB and MAPKs such as p38,
extracellular signal-regulated kinase (ERK), and c-Jun N-terminal kinase (JNK).
Conclusions: Our results indicate that the anti-inflammatory effects of GMSYS in RAW 264.7 macrophages are
associated with inhibition of the release of inflammatory mediators and cytokines through the suppression of MAPK
and NF-κB activation. These findings suggest that GMSYS may be a useful therapeutic candidate for the prevention
or treatment of inflammatory diseases.
Keywords: Gamisoyo-san, Inflammatory mediator, Cytokine, Mitogen-activated protein kinases (MAPKs), Nuclear
transcription factor kappa B (NF-κB)
Background
Inflammation is a complex process regulated by a cascade
of inflammatory mediators, including nitric oxide (NO),
prostaglandin E2 (PGE2), and cytokines, including tumor
necrosis factor-α (TNF-α) and interleukin-6 (IL-6), that
are produced by activated macrophages [1, 2].
NO is generated from L-arginine by nitric oxide synthase
(NOS) and plays an important role in the regulation of
physiological responses [3]. Among the isoforms of NOS,
the expression of inducible NOS (iNOS) is specifically stim-
ulated by cytokines and bacterial lipopolysaccharide (LPS)
[4]. Prostaglandins are key inflammatory mediators that are
produced from arachidonic acid by cyclooxygenase (COX).
Among the isoforms of COX, COX-2 is induced after ex-
posure to specific stimulants including cytokines and LPS.
The induction of COX-2 produces a large amount of PGE2
that causes inflammatory reactions [5]. These inflammatory
mediators and cytokines are critically associated with pain,
fever, edema, and recruitment of additional immune cells
to the site of inflammation [6]. However, overproduction of
inflammatory mediators and cytokines is associated with
tissue damage [7]. Therefore, inhibiting the release of
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inflammatory mediators and cytokines could be beneficial
in attenuating the damage caused by inflammatory
diseases.
Mitogen-activated protein kinases (MAPKs) such as
p38, extracellular signal-regulated kinase (ERK), and c-Jun
N-terminal kinase (JNK) regulate inflammatory and im-
mune responses, and their signaling pathways are involved
in LPS-induced iNOS and COX-2 expression in macro-
phages [8, 9]. In addition, nuclear transcription factor
kappa B (NF-κB) is crucial during inflammation [10]. The
regulatory free NF-κB translocates to the nucleus during
inflammation, where it binds to κB-binding sites in the
promotor regions of target genes and induces the tran-
scription of inflammatory mediators and cytokines such as
iNOS, COX-2, TNF-α, and IL-6 [11]. Thus, there may be
an opportunity to improve the development of the inflam-
matory response by regulating the activation of the MAPK
and NF-κB pathways.
In Korea, Gamisoyo-san (GMSYS) has been widely used
for the treatment of dysmenorrhea, insomnia, and anxiety
[12]. GMSYS is effective for treatment of sleep distur-
bances, headache, dizziness in postmenopausal women,
depressive symptoms in premenstrual dysphoric disorder,
and for tardive dyskinesia related to the use of anti-
psychotic drugs [13–15]. In addition, GMSYS has been
reported to exert antistress, antidepressive, and antioxi-
dant activities [12, 16–20]. Despite previous studies, there
have been no reports on the effects and molecular mecha-
nisms of GMSYS on inflammatory responses.
In the present study, we investigated the effect of GMSYS
on the expression and release of inflammatory mediators
and cytokines including NO, iNOS, PGE2, COX-2, TNF-α,
and IL-6 from LPS-stimulated RAW 264.7 macrophages.
In addition, we studied the molecular mechanisms possibly
involved in the regulation of inflammatory responses by
GMSYS.
Methods
Preparation of GMSYS water extract
The 12 raw herbal medicines composing the GMSYS for-
mula were purchased from a traditional herb market,
Kwangmyungdang Medicinal Herbs (Ulsan, Republic of
Korea). The 12 herbal medicines were authenticated by an
expert taxonomist, Prof. Je-Hyun Lee, Dongguk University,
Gyeongju, Republic of Korea. Voucher specimens were de-
posited at the K-herb Research Center, Korea Institute of
Oriental Medicine (2012–KE45–1 ~ KE45–11). To obtain a
water decoction of GMSYS, the 12 herbal medicines were
mixed as shown in Table 1 (total weight = 5.0 kg, about
141.8 times the composition of a single dose) and extracted
in distilled water at 100 °C for 2 h under pressure (98 kPa)
using an electric extractor (COSMOS-660; Kyungseo
Machine Co., Incheon, Korea). The extract was filtered
using a standard sieve (No. 270, 53 μm; Chung Gye Sang
Gong Sa, Seoul, Korea) and lyophilized to give a powder
sample. The yield of GMSYS extract was about 19.4 %
(970.4 g).
High-performance liquid chromatography (HPLC) analysis
of GMSYS
Quantitative analysis of the GMSYS sample was performed
using an LC-20A Prominence HPLC system (Shimadzu
Corp., Kyoto, Japan) equipped with a solvent delivery unit,
an on-line degasser, a column oven, an autosampler, and a
photo diode array (PDA) detector. Data were acquired and
processed using LabSolution software (version 5.54, SP3;
Shimadzu Corp.). Separation was achieved on a SunFire
C18 analytical column (250 × 4.6 mm; particle size 5 μm,
Waters, Milford, MA, USA) as the stationary phase at a
column temperature set to 40 °C. The mobile phases con-
sisted of 0.1 % (v/v) formic acid in water (A) and 0.1 % (v/v)
formic acid in acetonitrile (B). The gradient sequence and
elution conditions were as follows: 5–60 % B for 0–30 min,
60–100 % B for 30–40 min, 100 % B for 40–45 min, 100–
10 % B for 45–50 min, with a reequilibrium time of 10 min.
The flow-rate was 1.0 mL/min, and the sample injection
volume was 10 μL. For HPLC analysis, 200 mg of lyophi-
lized GMSYS extract was dissolved in 20 mL of distilled
Table 1 Composition of GMSYS
Latin name Scientific name Amount
(g)
Origin














Lycium chinense Miller 3.750 China
Angelicae
Gigantis Radix




Poria cocos Wolf 3.000 Pyeongchang,
Korea























Glycyrrhiza uralensis Fischer 1.125 China
Total 35.250
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water and then the solution diluted 10-fold for quantitative
analysis of geniposide and paeoniflorin. Samples were fil-
tered through a SmartPor GHP 0.2 μm syringe filter
(Woongki Science, Seoul, Korea) before application onto
the HPLC column.
Cell culture
The murine macrophage cell line, RAW 264.7, was ob-
tained from the American Type Culture Collection
(Rockville, MD). The cells were cultured in Dulbecco’s
modified Eagle’s medium (Gibco Inc., Grand Island, NY)
supplemented with 5.5 % heat-inactivated fetal bovine
serum (Gibco Inc.), penicillin (100 U/mL), and strepto-
mycin (100 μg/mL) in a 5 % CO2 incubator at 37 °C.
Cytotoxicity assay
A cell viability assay was performed to determine the cyto-
toxicity of GMSYS using a Cell Counting Kit-8 (CCK-8;
Dojindo Laboratories, Kumamoto, Japan). RAW 264.7
macrophages were plated into a 96-well microplate at 3 ×
103 cells/well and treated with various concentrations of
GMSYS for 24 h. After incubation with CCK-8 reagent for
4 h, optical density (OD) at 450 nm was measured by using
a Benchmark plus microplate reader (Bio-Rad Laboratories,
Hercules, CA). The cell viability was calculated using the
following equation:
Cell viability %ð Þ ¼ Mean OD in GMSYS treated cells
Mean OD in untreated cells
 100
NO assay
RAW 264.7 macrophages were pretreated with various
concentrations of GMSYS (0, 250, 500, or 1000 μg/mL) for
4 h and stimulated with LPS (1 μg/mL) for an additional
20 h. NO synthesis was determined by measuring the accu-
mulation of nitrite in the culture supernatant using a Griess
Reagent System (Promega, Madison, WI). Briefly, an equal
volume of supernatant and sulfanilamide solution was
mixed and incubated for 10 min at room temperature, and
then naphthylethylenediamine dihydrochloride solution
was added. The mixture was incubated for an additional
5 min, and its absorbance was measured at 540 nm using a
Benchmark plus microplate reader (Bio-Rad Laboratories).
The nitrite concentration in the supernatants was deter-
mined from a standard curve generated with sodium
nitrite.
ELISAs for PGE2, TNF-α, and IL-6
Production of PGE2, TNF-α, and IL-6 in the LPS-
stimulated RAW 264.7 macrophage culture supernatants
was measured using commercial ELISA kits from Cayman
Chemical Co. (Ann Arbor, MI), Invitrogen (Carlsbad, CA),
and BD Biosciences (Mountain View, CA), respectively.
RNA extraction and quantitative real-time polymerase
chain reaction (RT-qPCR)
Total RNA was extracted using Trizol reagent (Invitrogen
Life Sciences, Carlsbad, CA) according to the manufac-
turer’s instructions. Complementary DNA (cDNA) was
synthesized from 1 μg of total RNA using an iScript cDNA
synthesis kit (Bio-Rad Laboratories). RT-qPCR was per-
formed by using a Rotor Gene Q system (Qiagen, Hilden,
Germany) and a reaction mixture that consisted of SYBR
Green 2 × PCR Master Mix, cDNA template, and forward
and reverse primers. The PCR protocol consisted of 35 cy-
cles of denaturation at 95 °C for 15 sec, followed by 55 °C
for 30 s to allow for extension and amplification of the tar-
get sequence. The relative levels of iNOS and COX-2
mRNA expression were normalized to that of glyceralde-
hyde 3-phosphate dehydrogenase (GAPDH) using the 2-
ΔΔCT method. The primer sequences used in this study
are shown in Table 2.
Western blotting
RAW 264.7 macrophages were pretreated with GMSYS (0,
250, 500, or 1000 μg/mL) for 4 h and then treated with or
without LPS (1 μg/mL) for 15 min (to detect phosphoryl-
ation of protein), or for 20 h (to detect total protein).
Whole cell extract (WCE) was prepared by suspending the
macrophages in an extraction lysis buffer (Sigma-Aldrich,
St. Louis, MO) containing protease inhibitor cocktail
(Roche Applied Science, Indianapolis, IN). Nuclear extract
(NE) was isolated using NE-PER Nuclear and Cytoplasmic
Extraction reagents (Thermo Fisher Scientific, Rockford,
IL) according to the manufacturer’s protocol. The protein
concentration in the cell extracts was determined using a
Bio-Rad Protein Assay Reagent (Bio-Rad Laboratories).
Equal amounts of protein (30 μg) were resolved by 4–20 %
sodium dodecyl sulfate-polyacrylamide gel electrophoresis
(SDS-PAGE) and transferred to a polyvinylidene fluoride
(PVDF) membrane. The membrane was incubated with a
solution of 5 % skim milk in Tris-buffered saline contain-
ing Tween 20 (TBST) to block nonspecific binding sites,
followed by overnight incubation at 4 °C with an
Table 2 Nucleotide sequences of primers used in real-time RT-PCR
Gene Forward Reverse Accession no.
iNOS AAGGTCTACGTTCAGGACATC AGAAATAGTCTTCCACCTGCT NM_010927
COX-2 TTCCTCTACATAAGCCAGTGA TCCACATTACATGCTCCTATC NM_011198
GAPDH TGTGTCCGTCGTGGATCTGA CCTGCTTCACCACCTTCTTGA NM_008084
Jin et al. BMC Complementary and Alternative Medicine  (2016) 16:219 Page 3 of 11
appropriate primary antibodies; anti-phospho-p38 MAPK,
anti-phospho-ERK, anti-phospho-JNK (Cell Signaling,
Danvers, MA), anti-NF-κB p65, anti-β-actin, anti-α-
tubulin and anti-Lamin B (Santa Cruz Biotechnology,
Dallas, TX). The membranes were washed three times
with TBST, and then incubated with a corresponding
horseradish peroxidase-conjugated secondary antibody
(Jackson ImmunoResearch, West Grove, PA) for 1 h at
room temperature. The membranes were washed three
times with TBST again and then immunereactivity visual-
ized using an enhanced chemiluminescence (ECL)
(Thermo Fisher Scientific). Images were captured using
Chemi-Doc (Bio-Rad Laboratories).
Statistical analyses
The data are expressed as the mean ± SEM. Data were ana-
lyzed using a one-way analysis of variance and Dunnett’s
multiple comparisons test. P < 0.05 was considered to be
significant.
Results
Identification and quantification of the marker
components of GMSYS
We selected 11 components—including gallic acid,
neomangiferin, chlorogenic acid, mangiferin, geniposide,
paeoniflorin, berberine, liquiritin, nodakenin, glycyr-
rhizin, and atractylenolide III—as marker compounds
of GMSYS. Calibration curves for the 11 marker com-
ponents showed good linearity with correlation coeffi-
cients (r2) ≥ 0.9996 in their various concentration
ranges. Using optimized chromatography conditions, a
three-dimensional chromatogram was obtained using
HPLC–PDA detector, and the 11 compounds were
eluted within 35 min (Fig. 1). The concentrations of
gallic acid, neomangiferin, chlorogenic acid, mangi-
ferin, geniposide, paeoniflorin, berberine, liquiritin,
nodakenin, glycyrrhizin, and atractylenolide III were
0.58 ± 0.01, 0.45 ± 0.01, 0.90 ± 0.01, 1.99 ± 0.01, 8.37 ±
0.05, 8.91 ± 0.09, 2.01 ± 0.001, 0.94 ± 0.002, 1.43 ± 0.01,
0.81 ± 0.01, and 0.04 ± 0.001 mg/g, respectively.
Cytotoxicity of GMSYS in RAW 264.7 macrophages
To determine the cytotoxicity of GMSYS, RAW 264.7
macrophages were treated with GMSYS at various
concentrations ranging from 62.25 to 1000 μg/mL for
24 h, and a viability assay was conducted. As shown in
Fig. 2, GMSYS did not produce any significant cyto-
toxicity up to 1000 μg/mL. Subsequent experiments
were performed at nontoxic concentrations.
Fig. 1 Three-dimensional chromatogram of GMSYS by HPLC-PDA. The retention times of 11 marker compounds—gallic acid, neomangiferin,
chlorogenic acid, mangiferin, geniposide, paeoniflorin, berberine, liquiritin, nodakenin, glycyrrhizin, and atractylenolide III—were approximately
6.32, 10.82, 12.63, 13.04, 13.53, 15.17, 15.35, 16.61, 17.27, 29.86, and 34.00 min, respectively
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Effect of GMSYS on NO production and iNOS expression
in LPS-stimulated RAW 264.7 macrophages
The level of NO in culture supernatant was measured
using a Griess reaction. As shown in Fig. 3a, LPS treatment
significantly increased the level of NO compared with
vehicle-treated macrophages (P < 0.01). By contrast, LPS-
induced NO production was markedly reduced in macro-
phages pretreated with GMSYS (500 or 1000 μg/mL). A
positive control using N-methyl-L-arginine (L-NMMA,
100 μM) showed a significant decrease in LPS-induced
NO production.
To investigate the cause of reduced NO production by
GMSYS, the expression of iNOS by the macrophages was
determined by RT-qPCR. LPS treatment of the macro-
phages significantly increased the expression of iNOS com-
pared with vehicle-treated macrophages (P < 0.01). By
contrast, GMSYS (500 or 1000 μg/mL) pretreatment sig-
nificantly decreased the expression of LPS-induced iNOS
(P < 0.01, Fig. 3b).
Effect of GMSYS on PGE2 production and COX-2 expres-
sion in LPS-stimulated RAW 264.7 macrophages
As shown in Fig. 4a, LPS-treated macrophages pro-
duced significantly increased levels of PGE2 compared
with the vehicle-treated macrophages. By contrast,
pretreatment with GMSYS (250, 500, or 1000 μg/mL)
significantly decreased the level of PGE2 produced by
the LPS-stimulated macrophages compared with mac-
rophages treated with LPS alone (P < 0.01) (Fig. 3b).
Indomethacin (2.5 ng/mL) was used as a positive con-
trol and markedly decreased PGE2 production by the
stimulated macrophages.
To investigate whether the inhibitory effect of
GMSYS on PGE2 production was related to the ex-
pression of COX-2, we measured the COX-2 mRNA
expression using RT-qPCR. As shown in Fig. 4b, the
expression of COX-2 was significantly induced by LPS
stimulation (P < 0.01). By contrast, pretreatment of
macrophages with GMSYS (250, 500, or 1000 μg/mL)
markedly inhibited their LPS-induced COX-2 expres-
sion (P < 0.05, Fig. 4b).
Effect of GMSYS on the production of inflammatory
cytokines in LPS-stimulated RAW 264.7 macrophages
To determine the effect of GMSYS on the production
of proinflammatory cytokines TNF-α and IL-6, RAW
264.7 macrophages were pretreated with various con-
centrations of GMSYS (0, 250, 500, or 1000 μg/mL)
for 4 h and then stimulated with LPS (1 μg/mL) for
20 h. As shown in Fig. 5, the levels of TNF-α and IL-
6 were significantly increased in LPS-stimulated RAW
264.7 macrophages compared with vehicle-treated
macrophages (P < 0.01). By contrast, pretreatment of
the macrophages with GMSYS (250, 500, or 1000 μg/
mL) significantly decreased the levels of TNF-α in a
dose-dependent manner (P < 0.01) (Fig. 5a). LPS-
induced IL-6 levels were also reduced by pretreatment
of the macrophages with GMSYS (500 or 1000 μg/
mL) (P < 0.01, Fig. 5b).
Effect of GMSYS on MAPK phosphorylation in LPS-
stimulated RAW 264.7 macrophages
To clarify the molecular mechanism of the anti-
inflammatory effects of GMSYS, we analyzed the
phosphorylation of p38, ERK, and JNK by Western
blotting. As shown in Fig. 6a, GMSYS (250, 500, or
1000 μg/mL) decreased the expression of phosphory-
lated p38 in LPS-stimulated RAW 264.7 macrophages.
In addition, the phosphorylation of ERK and JNK was
Fig. 2 Effect of GMSYS on the cell viability in RAW 264.7 macrophages. The macrophages were treated with various concentrations of GMSYS (0,
62.5, 125, 250, 500, or 1000 μg/mL) for 24 h. Cell viability was measured using a CCK assay
Jin et al. BMC Complementary and Alternative Medicine  (2016) 16:219 Page 5 of 11
also reduced by pretreatment of GMSYS (500 or
1000 μg/mL).
Effect of GMSYS on NF-κB activation in LPS-stimulated
RAW 264.7 macrophages
To investigate the mechanism by which GMSYS re-
duces LPS-induced inflammatory responses, the nu-
clear translocation of NF-κB p65 was assessed by
Western blotting. As shown in Fig. 6b, nuclear NF-κB
p65 was markedly increased in the nucleus of LPS-
treated macrophages compared with the vehicle alone.
By contrast, pretreatment with GMSYS reduced the
nuclear translocation of NF-κB p65 in LPS-treated
macrophages compared with those without such
pretreatment.
Discussion
GMSYS, a traditional herbal formula comprising 12 differ-
ent herbal medicines—Paeoniae Radix, Atractylodis
Rhizoma Alba, Anemarrhenae Rhizoma, Lycii Radicis
Cortex, Angelicae Gigantis Radix, Poria Sclerotium, Liriope
Tuber, Rehmanniae Radix Crudus, Gardeniae Fructus,
Phellodendri Cortex, Platycodi Radix, and Glycyrrhizae
Radix et Rhizoma—has been used in Korea to treat dys-
menorrhea, insomnia, and anxiety [12]. Eleven of these 12
herbal medicines exhibit anti-inflammatory properties;
Fig. 3 Effect of GMSYS on the production of NO and expression of iNOS in LPS-stimulated RAW 264.7 macrophages. The macrophages were
pretreated with GMSYS for 4 h and then treated with LPS (1 μg/mL) for 20 h. a Collected supernatants were reacted with Griess reagent, and
absorbance was measured at 540 nm. b Total RNA was isolated from the cell pellets and subjected to RT-qPCR to detect the expression of
iNOS mRNA. Levels of iNOS mRNA expression were normalized to the expression of GAPDH mRNA. Bar graphs represent the means from three
independent experiments. ##P < 0.01 vs vehicle-treated cells and *P < 0.05 or **P < 0.01 vs LPS-treated cells
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namely, Paeoniae Radix [21], Atractylodis Rhizoma Alba
[22], Anemarrhenae Rhizoma [23], Lycii Radicis Cortex
[24], Angelicae Gigantis Radix [25], Poria Sclerotium [26],
Rehmanniae Radix Crudus [27], Gardeniae Fructus [28],
Phellodendri Cortex [29], Platycodi Radix [30], and Glycyr-
rhizae Radix et Rhizoma [31].
In the present study, we analyzed 11 marker compounds
found in an GMSYS—including gallic acid, neomangiferin,
chlorogenic acid, mangiferin, geniposide, paeoniflorin, ber-
berine, liquiritin, nodakenin, glycyrrhizin, and atractyleno-
lide III—using HPLC-PDA detector. Nine of these
compounds have anti-inflammatory effects; namely, gallic
acid [32], chlorogenic acid [33], mangiferin [34], geniposide
[35], paeoniflorin [36], berberine [37], nodakenin [38],
glycyrrhizin [39], and atractylenolide III [40]. For these
reasons, we predict that GMSYS, which contains these
anti-inflammatory herbal medicines and components, has a
preventive and therapeutic effect on inflammatory diseases.
However, the anti-inflammatory effect and mechanisms of
its action has not been thoroughly elucidated. Therefore,
we sought to investigate the anti-inflammatory effect and
molecular mechanisms of an extract of GMSYS in LPS-
stimulated RAW 264.7 macrophages, to our knowledge for
the first time. We found that GMSYS inhibited the release
of inflammatory mediators such as NO and PGE2, and
downregulated iNOS and COX-2 expression in LPS-
stimulated macrophages. These findings suggest that
GMSYS decreases NO and PGE2 levels by suppressing
iNOS and COX-2 expression, respectively.
TNF-α and IL-6 have been implicated in autoimmune
diseases including rheumatoid arthritis [41]. Therefore,
the measurement of TNF-α and IL-6 production may
Fig. 4 Effect of GMSYS on the production of PGE2 and expression of COX-2 in LPS-stimulated RAW 264.7 macrophages. The macrophages were pretreated
with GMSYS for 4 h and then treated with LPS (1 μg/mL) for 20 h. a PGE2 levels in supernatants were measures by ELISA. b Total RNA was isolated from
the cell pellets and subjected to RT-qPCR to detect the expression of COX-2 mRNA. Levels of COX-2 mRNA expression were normalized to the expression
of GAPDH mRNA. Bar graphs represent the means from three independent experiments. ##P< 0.01 vs vehicle-treated cells and **P< 0.01 vs
LPS-treated cells
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suggest an anti-inflammatory effect. In the present study,
we showed that GMSYS suppressed the production of
TNF-α and IL-6 in LPS-stimulated RAW 264.7
macrophages.
MAPK represents a group of signaling molecules that
appear to play critical roles in inflammatory processes. In
particular, they control cellular responses to cytokines and
play an important role in the modulation of NF-κB activity.
LPS activates three molecules involved in MAPK cascades,
p38, ERK, and JNK [42, 43]. To identify the signaling path-
ways involved in the GMSYS-mediated anti-inflammatory
responses, we investigated the phosphorylation of these
molecules by Western blotting. GMSYS diminished the
phosphorylation of p38, ERK, and JNK in LPS-stimulated
RAW 264.7 macrophages.
NF-κB plays an important role in various pathological
states as a transcription factor for iNOS, TNF-α, and IL-1β,
and is translocated into the nucleus by LPS stimulation
[44]. In the present study, we found that GMSYS attenu-
ated the nuclear translocation of p65 in LPS-stimulated
RAW 264.7 macrophages. These findings suggest that
GMSYS has an anti-inflammatory effect by inhibiting NF-
κB activation.
Although synthetic drugs have been used for treat-
ment of inflammatory diseases such as atherosclerosis,
many of them exhibit varying degrees of adverse ef-
fects [45]. By contrast, an examination of herbal med-
icines may contribute to the discovery of novel drugs
as potential anti-inflammatory agents with fewer side
effects. Some traditional herbal formulas produce
their anti-inflammatory effects by inhibiting the pro-
duction of inflammatory mediators by blocking NF-kB
activation in RAW 264.7 macrophages [46, 47]. These
reports and our findings suggest that natural products
Fig. 5 Effect of GMSYS on the production of TNF-α and IL-6 in LPS-stimulated RAW 264.7 macrophages. The macrophages were pretreated with
GMSYS (0, 250, 500, or 1000 μg/mL) for 4 h and then treated with LPS (1 μg/mL) for 20 h. ELISAs were used to determined levels of (a) TNF-α
and (b) IL-6 in collected supernatants. Bar graphs represent the means from three independent experiments. ##P < 0.01 vs vehicle-treated cells
and **P < 0.01 vs LPS-treated cells
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including GMSYS could be used as anti-inflammatory
agents with fewer adverse effects than synthetic
drugs.
Conclusions
In conclusion, the present study showed that GMSYS
inhibits the production and expression of NO, iNOS,
PGE2, COX-2, TNF-α, and IL-6 in LPS-stimulated
RAW 264.7 macrophages. These effects of GMSYS
are related to the suppression of MAPK and NF-κB
activation. Our results suggest that GMSYS should be
considered as a source of potent anti-inflammatory
candidates for the treatment or prevention of inflam-
matory diseases.
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